The Influence of the Microbiome on Early-Life Severe Viral Lower Respiratory Infections and Asthma-Food for Thought?
- PMID: 28261214
- PMCID: PMC5311067
- DOI: 10.3389/fimmu.2017.00156
The Influence of the Microbiome on Early-Life Severe Viral Lower Respiratory Infections and Asthma-Food for Thought?
Abstract
Severe viral lower respiratory infections are a major cause of infant morbidity. In developing countries, respiratory syncytial virus (RSV)-bronchiolitis induces significant mortality, whereas in developed nations the disease represents a major risk factor for subsequent asthma. Susceptibility to severe RSV-bronchiolitis is governed by gene-environmental interactions that affect the host response to RSV infection. Emerging evidence suggests that the excessive inflammatory response and ensuing immunopathology, typically as a consequence of insufficient immunoregulation, leads to long-term changes in immune cells and structural cells that render the host susceptible to subsequent environmental incursions. Thus, the initial host response to RSV may represent a tipping point in the balance between long-term respiratory health or chronic disease (e.g., asthma). The composition and diversity of the microbiota, which in humans stabilizes in the first year of life, critically affects the development and function of the immune system. Hence, perturbations to the maternal and/or infant microbiota are likely to have a profound impact on the host response to RSV and susceptibility to childhood asthma. Here, we review recent insights describing the effects of the microbiota on immune system homeostasis and respiratory disease and discuss the environmental factors that promote microbial dysbiosis in infancy. Ultimately, this knowledge will be harnessed for the prevention and treatment of severe viral bronchiolitis as a strategy to prevent the onset and development of asthma.
Keywords: PVM; RSV; asthma; microbiome; microbiota; microbiota and immunity; viral lower respiratory tract infection.
Figures
Similar articles
-
Early-Life Lung and Gut Microbiota Development and Respiratory Syncytial Virus Infection.Front Immunol. 2022 Apr 4;13:877771. doi: 10.3389/fimmu.2022.877771. eCollection 2022. Front Immunol. 2022. PMID: 35444639 Free PMC article. Review.
-
Alarmins and innate lymphoid cells 2 activation: A common pathogenetic link connecting respiratory syncytial virus bronchiolitis and later wheezing/asthma?Pediatr Allergy Immunol. 2022 Jun;33(6):e13803. doi: 10.1111/pai.13803. Pediatr Allergy Immunol. 2022. PMID: 35754131 Review.
-
Role of viral infections in the development and exacerbation of asthma in children.J Allergy Clin Immunol. 2017 Oct;140(4):895-906. doi: 10.1016/j.jaci.2017.08.003. J Allergy Clin Immunol. 2017. PMID: 28987219 Free PMC article. Review.
-
Nasal Microbiome and Its Interaction with the Host in Childhood Asthma.Cells. 2022 Oct 7;11(19):3155. doi: 10.3390/cells11193155. Cells. 2022. PMID: 36231116 Free PMC article. Review.
-
Airway microbiome, host immune response and recurrent wheezing in infants with severe respiratory syncytial virus bronchiolitis.Pediatr Allergy Immunol. 2020 Apr;31(3):281-289. doi: 10.1111/pai.13183. Epub 2020 Jan 22. Pediatr Allergy Immunol. 2020. PMID: 31788862
Cited by
-
Heterogeneity of Microbiota Dysbiosis in Chronic Rhinosinusitis: Potential Clinical Implications and Microbial Community Mechanisms Contributing to Sinonasal Inflammation.Front Cell Infect Microbiol. 2018 May 23;8:168. doi: 10.3389/fcimb.2018.00168. eCollection 2018. Front Cell Infect Microbiol. 2018. PMID: 29876323 Free PMC article.
-
Time to Say Goodbye to Bronchiolitis, Viral Wheeze, Reactive Airways Disease, Wheeze Bronchitis and All That.Front Pediatr. 2020 May 5;8:218. doi: 10.3389/fped.2020.00218. eCollection 2020. Front Pediatr. 2020. PMID: 32432064 Free PMC article. Review.
-
DP1 prostanoid receptor activation increases the severity of an acute lower respiratory viral infection in mice via TNF-α-induced immunopathology.Mucosal Immunol. 2021 Jul;14(4):963-972. doi: 10.1038/s41385-021-00405-7. Epub 2021 Apr 20. Mucosal Immunol. 2021. PMID: 33879829 Free PMC article.
-
Factors Affecting the Immunity to Respiratory Syncytial Virus: From Epigenetics to Microbiome.Front Immunol. 2018 Feb 19;9:226. doi: 10.3389/fimmu.2018.00226. eCollection 2018. Front Immunol. 2018. PMID: 29515570 Free PMC article. Review.
-
Molecular Accounting and Profiling of Human Respiratory Microbial Communities: Toward Precision Medicine by Targeting the Respiratory Microbiome for Disease Diagnosis and Treatment.Int J Mol Sci. 2023 Feb 17;24(4):4086. doi: 10.3390/ijms24044086. Int J Mol Sci. 2023. PMID: 36835503 Free PMC article. Review.
References
-
- Feldman AS, He Y, Moore ML, Hershenson MB, Hartert TV. Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma. Am J Respir Crit Care Med (2015) 191:34–44.10.1164/rccm.201405-0901PP - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources